ACKNOWLEDGEMENTS The authors would like to thank John Foss, BS for his assistance with the computer graphics. DISCLOSURES The authors have no relevant conflicts of interest to disclose.
Read More
INTRODUCTIONPsoriasis is a chronic immunologically driven inflammatory disease characterized by infiltration of the skin with activated T cells and by abnormal keratinocyte proliferation and differentiation, resulting in marked inflammation and…
Read More
INTRODUCTIONActinic keratosis (AK), a highly prevalent dermatologic condition resulting from long-term sun exposure,1,2 most commonly occurs in older individuals and those with fair skin.1-3 AKs are typically present as red,…
Read More
INTRODUCTIONHidradenitis suppurativa (HS) is a chronic, often recalcitrant condition that primarily affects apocrine glandbearing skin in the axillae, groin and buttocks. Histopathologic studies show that follicular occlusion rather than inflamed…
Read More
INTRODUCTIONThe majority of changes we associate with aging are the results of chronic photodamage and include five main features: fine lines and wrinkles, enlarged pores, sagging skin, telangiectasias and dyschromia…
Read More
INTRODUCTIONTumour necrosis factor-α (TNFα) inhibitors have changed the way we treat patients that suffer with moderate to severe chronic plaque psoriasis (PsO). Three TNF inhibitors have been approved by the…
Read More
INTRODUCTION Cutaneous T-cell lymphomas (CTCL) are a heterogeneous group of diseases with diverse clinical manifestations and prognoses. Standard treatments for early stage CTCL include topical corticosteroids, imiquimod, psoralen and ultraviolet…
Read More
INTRODUCTIONThe association between systemic retinoids and the development of affective disorders has been debated for many years. Recent studies have elucidated possible neurological mechanisms by which retinoids might mediate affective…
Read More
INTRODUCTION Povidone-iodine (trade name Betadine, Purdue, Stamford, NJ) is a widely used antiseptic regarded for its broad antimicrobial spectrum, fast onset of action and favorable safety profile. It consists of…
Read More
CASE REPORT A 66-year-old man from Guyana, who had been living in the United States for twelve years, was treated with prednisone 60 mg orally daily for approximately one year,…
Read More
CASE REPORT A 27-year-old Caucasian woman with a history of cryptogenic renal failure presented with a 1.5-year history of asymptomatic papules on her central face, which developed six months after…
Read More
ACNE A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris Sponsored by Dow Pharmaceutical Sciences. The purpose of this study is to evaluate the…
Read More






